Only two out of the six patients that required treatment carried STAT3 mutations, presented neutropenia and CD3− CD16+ CD56dim CD57− immunophenotype (Supplementary Table 2), in accordance with Barilà et al.16. Here, STAT3 is linked to neutropenia.